J
James Melrose
Researcher at University of New South Wales
Publications - 186
Citations - 6893
James Melrose is an academic researcher from University of New South Wales. The author has contributed to research in topics: Perlecan & Intervertebral disc. The author has an hindex of 41, co-authored 170 publications receiving 5861 citations. Previous affiliations of James Melrose include University of Sydney & Cardiff University.
Papers
More filters
Journal ArticleDOI
Are animal models useful for studying human disc disorders/degeneration?
Mauro Alini,Stephen M. Eisenstein,Keita Ito,Christopher B. Little,Annette Kettler,Koichi Masuda,James Melrose,James Robert Ralphs,Ian A. F. Stokes,Hans-Joachim Wilke +9 more
TL;DR: Although animal models are invaluable to increase the understanding of disc biology, care must be taken when used to study human disc degeneration and much more effort is needed to facilitate research on human disc material.
Journal ArticleDOI
Diverse cell signaling events modulated by perlecan.
TL;DR: The pro-angiogenic capacities of perlecan that involve proliferative and migratory signals in response to bound growth factors will be explored, as well as the anti-angIogenic signals resulting from interactions between the C-terminal domain known as endorepellin and integrins that control adhesion of cells to the extracellular matrix.
Journal ArticleDOI
Increased Nerve and Blood Vessel Ingrowth Associated With Proteoglycan Depletion in an Ovine Anular Lesion Model of Experimental Disc Degeneration
TL;DR: The ovine anular lesion model of disc degeneration is a useful experimental model for the systematic evaluation of nerve and blood vessel development after anular injury and early focal depletion 3–12 months postoperation of glycosaminoglycan was demonstrated.
Journal ArticleDOI
Proteoglycan degradation by the ADAMTS family of proteinases.
TL;DR: This review focuses onADAMTS enzymes that degrade the lectican and small leucine-rich repeat families of proteoglycans, and discusses the known ADAMTS cleavage sites and the consequences of cleavage at these sites.
Journal ArticleDOI
Not All Perlecans Are Created Equal INTERACTIONS WITH FIBROBLAST GROWTH FACTOR (FGF) 2 AND FGF RECEPTORS
Sarah M. Knox,Sarah M. Knox,Catherine L.R. Merry,Sally E. Stringer,James Melrose,John M. Whitelock +5 more
TL;DR: Data show that perlecans immunopurified from three cellular sources possess different HS structures and subsequently different FGF-2 binding and activating capabilities, and that subtle changes in structure including secondary interactions have a profound effect on biological activity.